European Journal of Cancer
Volume 41, Issue 18 , Pages 2853-2860 , December 2005

Differential sensitivity of liposarcoma subtypes to chemotherapy

Received 19 May 2005 ,Revised 7 July 2005 ,Accepted 7 July 2005.

References 

  1. Weiss SW, Goldblum JR. Enzinger and Weiss’s soft tissue tumours. 4th ed.. St. Louis (MO): Mosby; 2001;p. 641–93
  2. Kilpatrick SE, Doyon J, Choong PFM, et al. The clinicopathologic spectrum of myxoid and round cell liposarcoma: a study of 95 cases. Cancer. 1996;77:1450–1458
  3. Spillane AJ, Fisher C, Thomas JM. Myxoid liposarcoma – the frequency and the natural history of nonpulmonary soft tissue metastases. Ann Surg Oncol. 1999;6:389–394
  4. Pearlstone DB, Pisters PW, Bold RJ, et al. Patterns of recurrence in extremity liposarcoma: implications for staging and follow-up. Cancer. 1999;85:85–92
  5. Smith TA, Easley KA, Goldblum JR. Myxoid/round cell liposarcoma of the extremities. A clinicopathologic study of 29 cases with particular attention to extent of round cell liposarcoma. Am J Surg Pathol. 1996;20:171–180
  6. Knight JC, Renwick PJ, Clin PD, et al. Translocation t(12;16) (q13;p11) in myxoid liposarcoma and round cell liposarcoma: molecular and cytogenetic analysis. Cancer Res. 1995;55:24–27
  7. Lucas DR, Nascimento AG, Sanjay BKS, et al. Well-differentiated liposarcoma: the Mayo clinic experience with 58 patients. Am J Clin Pathol. 1994;102:677–683
  8. Henricks WH, Chu YC, Goldblum JR, et al. Dedifferentiated liposarcoma: a clinicopathological analysis of 155 cases with a proposal for an expanded definition of dedifferentiation. Am J Surg Pathol. 1997;21:271–281
  9. Rubin BP, Fletcher CDM. The cytogenetics of lipomatous tumours. Histopathology. 1997;30:507–511
  10. Downes KA, Goldblum JR, Montgomery EA, et al. Pleomorphic liposarcoma: a clinicopathological analysis of 19 cases. Mod Pathol. 2001;14:179–184
  11. Patel SR, Burgess MA, Plager C, et al. Myxoid liposarcoma – experience with chemotherapy. Cancer. 1994;74:1265–1269
  12. Trojani M, Contesso G, Coindre JM, et al. Soft-tissue sarcomas of adults; study of pathological variables and definitions of a histopathological grading system. Int J Cancer. 1984;33:37–42
  13. Guillou L, Coindre JM, Bonichon F, et al. Comparative study of the National Cancer Institute and French Federation of Cancer Centres Sarcoma Group grading systems in a population of 410 adult patients with soft tissue sarcomas. J Clin Oncol. 1997;15:350–362
  14. Kaplan EL, Meier P. Non parametric estimation from incomplete observations. J Am Stat Soc. 1958;53:457–481
  15. Cox DR. Regression models and life tables (with discussion). J R Stat Soc B. 1972;34:187–220
  16. Van Glabbeke M, van Oosterom AT, Oosterhuis JW, et al. Prognostic factors for the outcome of chemotherapy in advanced soft tissue sarcoma: an analysis of 2185 patients treated with anthracycline-containing first-line regimens – a European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Study. J Clin Oncol. 1999;17:150–157
  17. Eilber FC, Eilber FR, Eckardt J, et al. The impact of chemotherapy on the survival of patients with high-grade primary extremity liposarcoma. Ann Surg. 2004;240:686–695
  18. Gebhard S, Coindre J-M, Michels JJ, et al. Pleomorphic liposarcoma: clinicopathologic, immunohistochemical and follow-up analysis of 63 cases. Am J Surg Pathol. 2002;26:601–616
  19. Oliveira AM, Nascimento AG. Pleomorphic liposarcoma. Semin Diagn Pathol. 2001;18:274–285
  20. Hensley ML, Maki R, Venkatraman E, et al. Gemcitabine and docetaxel in patients with unresectable leiomyosarcoma: results of a phase II trial. J Clin Oncol. 2002;20:2824–2831

PII: S0959-8049(05)00796-3

doi: 10.1016/j.ejca.2005.07.023

European Journal of Cancer
Volume 41, Issue 18 , Pages 2853-2860 , December 2005

Article Tools

* Image Usage & Resolution